These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 11859)
1. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859 [TBL] [Abstract][Full Text] [Related]
2. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Storb R; Weiden PL; Sullivan KM; Appelbaum FR; Beatty P; Buckner CD; Clift RA; Doney KC; Hansen J; Martin PJ Blood; 1987 Jul; 70(1):116-21. PubMed ID: 3297199 [TBL] [Abstract][Full Text] [Related]
3. Marrow transplant experience for children with severe aplastic anemia. Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172 [TBL] [Abstract][Full Text] [Related]
4. Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia. Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC Am J Hematol; 2002 Jan; 69(1):15-22. PubMed ID: 11835325 [TBL] [Abstract][Full Text] [Related]
5. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. Peinemann F; Bartel C; Grouven U Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658 [TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Storb R; Etzioni R; Anasetti C; Appelbaum FR; Buckner CD; Bensinger W; Bryant E; Clift R; Deeg HJ; Doney K Blood; 1994 Aug; 84(3):941-9. PubMed ID: 8043876 [TBL] [Abstract][Full Text] [Related]
7. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
8. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Thomas ED; Buckner CD; Banaji M; Clift RA; Fefer A; Flournoy N; Goodell BW; Hickman RO; Lerner KG; Neiman PE; Sale GE; Sanders JE; Singer J; Stevens M; Storb R; Weiden PL Blood; 1977 Apr; 49(4):511-33. PubMed ID: 14751 [TBL] [Abstract][Full Text] [Related]
9. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center. Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353 [TBL] [Abstract][Full Text] [Related]
11. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193 [TBL] [Abstract][Full Text] [Related]
12. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Deeg HJ; Amylon ID; Harris RE; Collins R; Beatty PG; Feig S; Ramsay N; Territo M; Khan SP; Pamphilon D; Leis JF; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B Biol Blood Marrow Transplant; 2001; 7(4):208-15. PubMed ID: 11349807 [TBL] [Abstract][Full Text] [Related]
13. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750 [TBL] [Abstract][Full Text] [Related]
14. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487 [TBL] [Abstract][Full Text] [Related]
15. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation. Min CK; Kim DW; Lee JW; Min WS; Kim CC Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation for severe aplastic anemia. A report of 9 cases. Marmont AM; Van Lint MT; Avanzi G; Reali G; Adami R; Soldá A; Strada P; Barbanti M; Mingari MC; Soro O; Grazi G; Pedullá D; Cerri R; Rossi E; Giordano D; Santini G; Carella A; Risso M; Vimercati R; Piaggio G; Raffo MR; Librace E; Vitale V; Bacigalupo A Acta Haematol; 1979; 62(3):121-7. PubMed ID: 43062 [TBL] [Abstract][Full Text] [Related]